NCI Surveillance Support 2010-2015

The National Institutes of Health National Cancer Institute (NCI) awarded this Master IDIQ on September 24, 2010, with ordering authority ending September 23, 2015—this vehicle is no longer active. The shared ceiling was $30 million; task orders totaling $12.4 million in combined potential value were issued, with $12.1 million obligated (97% of potential value). The vehicle funded cancer surveillance research across three categories: rapid response to emerging issues, evaluation, and methods development.

Ten task orders were awarded over the vehicle's five-year life, with ordering concentrated in 2010 (five orders) and trailing to one order in 2013 and two orders each in 2014 and 2015. All orders were unrestricted (no set-aside designations used) and served only the NCI.

Westat, Inc. dominated by combined potential value, holding three orders worth $9.2 million. Research Triangle Institute held five orders but smaller aggregate value at $3.2 million. Social & Scientific Systems, Inc. and ABT Global LLC each held one order, both with $0 combined potential value (administrative task orders that were de-obligated). The two-firm concentration—Westat and Research Triangle—captured approximately 97% of awarded potential value.

Awarded task orders show the vehicle funded survey design, implementation, and analysis work: the National Survey of Precision Medicine in Cancer Treatment (survey design and implementation phases), management and coordination for the Latin America Cancer Research Network, biomarker validation studies, and program evaluation and coordination services. Order values ranged from de-obligated administrative orders to the largest award, a $5.2 million cost-plus-fixed-fee delivery order to manage and coordinate the Latin America Cancer Research Network (performance period September 2015–June 2020). Most substantive orders used cost-plus-fixed-fee pricing; one 2015 order employed firm-fixed-price structure.

This vehicle is closed and no longer available for new task orders.

The Division of Cancer Control and Population Sciences (DCCPS) of the National Cancer Institute (NCI) supports an integrated extramural program of cancer epidemiologic, genetic, behavioral, social, health services and economics, outcomes, and surveillance research. The major objective of the surveillance research is to monitor and explain patterns in the national cancer burden, including trends in cancer incidence, mortality, survival, risk factors, and the delivery of preventive and therapeutic health services. The primary approach for obtaining information about cancer trends is through the conduct of surveys and evaluation studies, and the development and validation of methods for surveillance activities. As such, contractors under this Master Vehicle perform surveillance projects that fall under three broad categories: (1) rapid response to emerging issues; (2) evaluation, and; (3) methods development.